These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20053563)

  • 41. Research progress on the structural characterization, biological activity and product application of polysaccharides from Crataegus pinnatifida.
    Jing Y; Yan M; Liu D; Tao C; Hu B; Sun S; Zheng Y; Wu L
    Int J Biol Macromol; 2023 Jul; 244():125408. PubMed ID: 37343606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.
    Paemen L; Martens E; Norga K; Masure S; Roets E; Hoogmartens J; Opdenakker G
    Biochem Pharmacol; 1996 Jul; 52(1):105-11. PubMed ID: 8678893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crataegusins A and B, New Flavanocoumarins from the Dried Fruits of Crataegus pinnatifida var. major (Rosaceae).
    Kazuma K; Isobe Y; Asahina H; Nehira T; Satake M; Konno K
    Nat Prod Commun; 2016 Jul; 11(7):965-969. PubMed ID: 30452173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening of selected basidiomycetes for inhibitory activity on Clostridium histolyticum collagenase and human leukocyte elastase.
    Rennert B; Melzig MF
    Phytother Res; 2002 Mar; 16 Suppl 1():S81-3. PubMed ID: 11933148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Isolation of the total flavonoids from the leaves of Crataegus curvisepala Lindm].
    BATIUK VS; PROKOPENKO AP; KOLESNIKOV DG
    Med Prom SSSR; 1963 Jan; 17():22-5. PubMed ID: 13966812
    [No Abstract]   [Full Text] [Related]  

  • 46. [ISOLATION AND CHEMICAL PROPERTIES OF FLAVONOIDS OBTAINED FROM CRATAEGUS CURVISEPALA LINDM. LEAVES].
    BATIUK VS
    Farm Zh; 1964; 19():47-50. PubMed ID: 14296072
    [No Abstract]   [Full Text] [Related]  

  • 47. Three new sesquineolignans from the fruits of
    Zhao P; Qiu S; Yu XQ; Yao GD; Huang XX; Song SJ
    J Asian Nat Prod Res; 2021 Nov; 23(11):1051-1056. PubMed ID: 33327778
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gelatinase and collagenase production by certain species of Bacillus.
    EVANS DG; WARDLAW AC
    J Gen Microbiol; 1953 Jun; 8(3):481-7. PubMed ID: 13061752
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results in studies on Crataegus. II. Experimental findings with total extracts and isolated purified substances of Crataegus].
    BOHM K
    Arzneimittelforschung; 1956 Jan; 6(1):38-41. PubMed ID: 13293097
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pharmacodynamics of triterpenic acids of Crataegus; Crataegus acids].
    DORNER J; KUSCHKE HJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1955; 224(1):24-43. PubMed ID: 13235903
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pharmacodynamic effect of triterpenic acids from Crataegus (Crataegus acids)].
    DORNER J; KUSCHKE HJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1955; 225(1-2):144-7. PubMed ID: 14394190
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pharmacology of Crataegus extracts (esbericard); remarks on H. Layer's paper].
    DAWEKE H; GIERTZ H
    Munch Med Wochenschr; 1957 Dec; 99(52):1983-4. PubMed ID: 13504082
    [No Abstract]   [Full Text] [Related]  

  • 53. [A CONTRIBUTION TO CRATAEGUS INDICATIONS].
    LEONHARD H
    Med Welt; 1963 Sep; 38():1943-5. PubMed ID: 14056584
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of Crataegus extracts on the dynamics of the human heart].
    ECHTE W
    Arztl Forsch; 1960 Nov; 14():560-6. PubMed ID: 13725582
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical experiences with an injectable Crataegus preparation].
    HABERECHT I
    Med Klin; 1957 Feb; 52(5):185-7. PubMed ID: 13418230
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pharmacological testing of a substance isolated from Crataegus. Part 10].
    SCHWABE W; NEU R
    Arzneimittelforschung; 1960 Jan; 10():60-1. PubMed ID: 14443939
    [No Abstract]   [Full Text] [Related]  

  • 57. [CURRENT STATUS AND LIMITATIONS OF THE USE OF CRATAEGUS EXTRACTS IN CARDIOLOGICAL THERAPY IN THE AGED].
    ROCCOLOCATELLI G; GHIRINGHELLI F; TRONCONI L
    Clin Ter; 1964 Mar; 28():442-54. PubMed ID: 14138945
    [No Abstract]   [Full Text] [Related]  

  • 58. [Indication and clinical results with crataegus therapy].
    FASSHAUER W
    Dtsch Med Wochenschr; 1951 Feb; 76(7):211. PubMed ID: 14813045
    [No Abstract]   [Full Text] [Related]  

  • 59. [Crataegus in therapy of attrition diseases of the circulatory system].
    STORCH H
    Z Gesamte Inn Med; 1957 May; 12(9):400-5. PubMed ID: 13456746
    [No Abstract]   [Full Text] [Related]  

  • 60. [New advances in research on Crataegus].
    ULLSPERGER R
    Pharmazie; 1953 Jul; 8(7):596-7. PubMed ID: 13111884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.